Studying snakebites in Assiut, Egypt
Part of Injuries & trauma clinical trials.
This study looks at people who have been bitten by a snake to learn more about how snakebites affect the body and what treatments work best. It may help doctors improve care for future snakebite patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been bitten by a snake and it is clear from the story or marks on your body.
- You must have signs of poisoning from the bite (like swelling, pain, or other symptoms).
- You cannot have a blood disorder, liver disease, kidney disease, or have taken blood thinners in the last week.
- You must be willing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new scoring system to predict how serious a snakebite is and what symptoms may develop. If you've been bitten by a snake in the last 24 hours, this study could help improve care for others like you.
This trial tests a snake antivenom called PANAF-Premium to see if it is safe and works well for people bitten by snakes. It is for anyone with signs of venom poisoning, and you can join even if you have had other snakebite treatments or are pregnant.
This trial tests an oral medication for people who have been bitten by a snake in the past 12 hours. The goal is to see if it can help reduce the effects of the venom.
This trial studies how useful a quick, bedside ultrasound exam is for assessing snake bites. If you’re an adult with a snake bite, the study may help doctors see what’s going on faster to guide treatment.
This study is testing a new polyvalent antivenom called Premium-PANAF for treating snakebites in Ethiopia. It aims to see how well the antivenom works for people who have been bitten by venomous snakes.
This study asks households about snakebites to understand where and how often they happen. Your participation helps researchers learn how to reduce snakebite risks.
Hear when a new Snakebite Cases Evaluation Clinical and Laboratory trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.